Establishment Labs Holdings (ESTA) Change in Receivables (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Change in Receivables of -$302000.0 for Q1 2026, up 61.03% year-over-year from -$187540.1 in Q1 2025, and down 104.67% quarter-over-quarter from $6.5 million in Q4 2025.
Establishment Labs Holdings (ESTA) Change in Receivables (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Change in Receivables history runs 10 years deep, the most recent figure standing at -$302000.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 61.03% year-over-year to -$302000.0; the TTM figure through Mar 2026 stood at $11.9 million (down 42.85% YoY), while the FY2025 annual figure was $11.5 million, down 56.36% from the prior year.
- Change in Receivables for Q1 2026 stood at -$302000.0, down from $6.5 million in the prior quarter.
- The five-year high for Change in Receivables was $9.6 million in Q2 2023, with the low at -$8.1 million in Q4 2023.
- The 5-year median for Change in Receivables is $4.6 million (2024), against an average of $3.6 million.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables surged 2550.0% in 2022, then sank 429.67% in 2023.
- Establishment Labs Holdings' Change in Receivables stood at $2.4 million in 2022, then tumbled by 429.67% to -$8.1 million in 2023, then surged by 163.71% to $5.1 million in 2024, then increased by 25.79% to $6.5 million in 2025, then slumped by 104.67% to -$302000.0 in 2026.
- Business Quant data shows ESTA's Change in Receivables at -$302000.0 in Q1 2026, $6.5 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | -1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.52 Mn |
| Jun 30, 2026 | -1.52 Mn |
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | 6.47 Mn |
| Dec 31, 2025 | 6.47 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Jun 30, 2025 | 4.46 Mn |
| Mar 31, 2025 | -775,000.00 |
| Mar 31, 2025 | -775,000.00 |
| Dec 31, 2024 | 5.15 Mn |
| Dec 31, 2024 | 5.15 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Sep 30, 2024 | 6.91 Mn |
| Jun 30, 2024 | 9.62 Mn |
| Jun 30, 2024 | 9.62 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Mar 31, 2024 | 4.61 Mn |